Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.47 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TET2 | Q6N021 | 6/20 | 0.39 |
| ▸ | TET3 | O43151 | 2/20 | 0.39 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 2/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27542310 | 0.96 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL28275674 | 0.89 | MMP1 (0.52) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL2845135 | 0.88 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| Malic Acid SCHEMBL27687431 | 0.82 | SMN1; SMN2 (0.50) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL1168152 | 0.80 | MMP1 (0.42) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL11574916 | 0.80 | MMP1 (0.44) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL23630284 | 0.78 | TSHR (0.41) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL11574927 | 0.77 | MMP1 (0.42) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL9006278 | 0.77 | MMP1 (0.39) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL7118530 | 0.77 | MMP1 (0.39) | MMP1MMP2MMP3MMP9MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220016020-A1 | SKIN DULLNESS SUPPRESSING AGENT, AND SKIN BARRIER FUNCTION MAINTAINING OR IMPROVING AGENT | EZAKI GLICO CO., LTD. (JP) | 2022-01-20 | — | — | US | claimed |
| JP-59033364-A | — | — | None | — | — | JP | disclosed |
| US-12037334-B2 | Inhibitors of VAP-1 | ACUCELA INC. (US) | 2024-07-16 | — | — | US | disclosed |
| EP-4392521-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024130110-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20240165098-A1 | OPHTHALMIC COMPOSITION | Sydnexis, Inc. | 2024-05-23 | — | — | US | disclosed |
| US-20240139166-A1 | OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA | Sydnexis, Inc. | 2024-05-02 | — | — | US | disclosed |
| US-20240091367-A1 | ORALLY DISINTEGRATING PALATABLE FORMULATIONS OF DROTAVERINE AND METHOD OF PREPARATION THEREOF | SUSHMA PAUL BERLIA (IN) | 2024-03-21 | — | — | US | disclosed |
| WO-2024033786-A1 | METHOD FOR TRIETHYLENETETRAMINE PURIFICATION | PHILERA NEW ZEALAND LTD. (NZ) | 2024-02-15 | — | — | WO | disclosed |
| US-11896588-B2 | Ophthalmic composition | Sydnexis, Inc. (US) | 2024-02-13 | — | — | US | disclosed |
| WO-1999032436-A1 | INHIBITION OF RAF KINASE USING SYMMETRICAL AND UNSYMMETRICAL SUBSTITUTED DIPHENYL UREAS | BAYER CORPORATION (US) | 1999-07-01 | — | — | WO | disclosed |
| WO-1998016192-A1 | GERMICIDAL COMPOSITION | ALTERNA, INC. (US) | 1998-04-23 | — | — | WO | disclosed |
| US-5670344-A | Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts | THE PROCTER & GAMBLE COMPANY (US) | 1997-09-23 | — | — | US | disclosed |
| WO-1997027758-A1 | IRON FORTIFIED CHOCOLATE-FLAVORED BEVERAGES INCLUDING EDIBLE ACIDS OR THEIR SALTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-07 | — | — | WO | disclosed |
| EP-0182210-B1 | CEPHALOSPORIN DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-02-27 | — | — | EP | disclosed |
| US-4742053-A | ANTIBIOTICS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1988-05-03 | — | — | US | disclosed |
| US-4677100-A | ANTIBIOTICS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1987-06-30 | — | — | US | disclosed |
| EP-0182210-A2 | Cephalosporin derivatives | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1986-05-28 | — | — | EP | disclosed |
| JP-S5933364-A | PREPARATION OF MICA-BASE PEARLESCENT PIGMENT | SANYO SHIKISO KK | 1984-02-23 | — | — | JP | disclosed |
| US-4009173-A | Butyrophenone derivatives | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11896588-B2 | Ophthalmic composition | MYOC, PDE6H, PDE6C | MMP1 426/4885MMP2 1921/4885MMP3 279/4885 |
| US-20240139166-A1 | OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA | CRYZ, CRYAB, AQP3 | MMP1 3333/4885MMP2 3914/4885MMP3 2042/4885 |
| US-12037334-B2 | Inhibitors of VAP-1 | VAPB, VAPA, TOE1 | MMP1 373/4885MMP2 148/4885MMP3 114/4885 |
| US-20240165098-A1 | OPHTHALMIC COMPOSITION | MYOC, PDE6H, PDE6C | MMP1 426/4885MMP2 1921/4885MMP3 279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.